Biohaven Ltd.
BHVN
$15.61
$0.936.34%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -198.15M | -221.68M | -186.84M | -160.30M | -319.77M |
| Total Depreciation and Amortization | 1.98M | 2.25M | 2.46M | 1.99M | 1.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.68M | 58.67M | 19.66M | -3.48M | 173.33M |
| Change in Net Operating Assets | 18.56M | -4.37M | -6.02M | 20.52M | -23.31M |
| Cash from Operations | -167.94M | -165.12M | -170.74M | -141.28M | -167.80M |
| Capital Expenditure | -233.00K | -461.00K | -49.00K | -611.00K | -2.95M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -391.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.31M | 165.34M | -87.63M | -92.79M | -94.59M |
| Cash from Investing | -15.55M | 164.88M | -87.68M | -93.40M | -97.93M |
| Total Debt Issued | 250.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.08M | 369.00K | 282.79M | 76.36M | 320.89M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.25M | -- | -9.93M | 4.01M | 238.00K |
| Cash from Financing | 249.83M | 369.00K | 272.85M | 80.38M | 321.12M |
| Foreign Exchange rate Adjustments | -40.00K | 23.00K | 88.00K | 0.00 | -7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.31M | 147.00K | 14.52M | -154.30M | 55.39M |